腹膜肿瘤外科近五年学术论文

[1] Li XB, Ma R, Ji ZH, Lin YL, Zhang J, Yang ZR, Chen LF, Yan FC, Li Y*(corresponding author). Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center. Eur J Surg Oncol. 2020; 46 (4 Pt A): 600-606. (IF=3.379)

[2] Yan FC, Lin YL, Zhou Q, Chang H, Li Y*(corresponding author). Pathological Prognostic Factors of Pseudomyxoma Peritonei: Comprehensive Clinicopathological Analysis of 155 Cases. Hum Pathol. 2020; pii S0046-8177(0020)30008-30003. (IF=2.740)

[3] Lin YL, Zhang J, Yan FC, Jiang X, Ma R, Yang ZR, Xu HB, Peng Z, Chen Q, Li Y*(corresponding author). Establishment of patient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracil. Cancer Med. 2019; 00: 1-11. (IF=3.357)

[4] Li XB, Peng KW, Ji ZH, Yu Y, Liu G, Li Y*(corresponding author). Prevention of venous thromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Development of a physiotherapy program. Clin Appl Thromb Hemost. 2019; 25: 1-8. (IF=1.846)

[5] Ji ZH, An SL, Li XB, Liu G, Li Y*(corresponding author). Long-term progression-free survival of hepatocellular carcinoma with synchronous diffuse peritoneal metastasis treated by CRS+HIPEC: A case report and literature review. Medicine (Baltimore). 2019; 98(08): e14628. (IF= 1.870)

[6] Peng CW, Liu JY, Yang GF, Li Y*(corresponding author). The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system. J Gastroenterol. 2018; 53(5): 606-617. (IF= 3.438)

[7] Liu J, Huang C, Peng C, Xu F, Li Y*(corresponding author), Yutaka Y, Xiong B, Yang X. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway. BMC Cancer. 2018; 18(1): 1099. (IF = 2.933) (cited by 1)

[8] Liu JY, Peng CW, Yang XJ, Huang CQ, Li Y*(corresponding author). The prognosis role of AJCC/UICC 8th edition staging system in gastric cancer, a retrospective analysis. Am J Transl Res. 2018; 10(1): 292-303. (IF = 3.266) (cited by 15)

[9] Zhang J, Yuan JP, Wang Q, Shao LH, Liu SP, Firestone RA, Hong YP, Li JG, Xin YC, Li Y*(corresponding author). Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer. Oncotarget. 2018; 9(2): 1957. (cited by 0)

[10] Peng C, Liu J, Yang G, Li Y*(corresponding author). Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: quantum dot-based identification of biomarkers in cancer stromal cells. Int J Nanomed. 2018; 13: 161-174. DOI: 10.2147/IJN.S143871. (IF=4.370)

[11] Liu G, Ji ZH, Yu Y, Li XB, Zhang YB, Peng KW, Li Y*(corresponding author). Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: a retrospective comparative study. Medicine (Baltimore). 2017; 96(45): e8573. DOI: 10.1097/MD.0000000000008573. (IF = 1.804)

[12] Peng CW, Liu JY, Yang GF, Li Y*(corresponding author). The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system. J Gastroenterol. 2018; 53(5): 606-617. DOI: 10.1007/s00535-017-1379-1. (IF = 5.130)

[13] Fang M, Chen M, Liu LL, Li Y*(corresponding author). Applications of quantum dots in cancer detection and diagnosis: a review. J Biomed Nanotechnol. 2017; 13(1): 1-16. DOI: 10.1166/jbn.2017.2334. (IF = 4.521)

[14] Liu JY, Peng CW, Yang GF, Hu WQ, Yang XJ, Xiong B, Li Y*(corresponding author). Distribution pattern of tumor associated macrophages predicts the prognosis of gastric cancer. Oncotarget. 2017; 8(54): 92757-92769. DOI: 10.18632/oncotarget.21575. (IF = 5.168)

[15] Huang CQ, Min Y, Wang SY, Yang XJ, Liu Y, Xiong B, Yonemura Y, Li Y*(corresponding author). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence. Oncotarget. 2017. DOI: 10.18632/oncotarget.17497. (IF = 5.168) (cited by 0)

[16] Yuan J, He L, Han B, Li Y*(corresponding author). Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review. World J Surg Oncol. 2017; 15(1):76. DOI: 10.1186/s12957-017-1134-3. (IF = 1.600) (cited by 0)

[17] Yonemura Y, Endo Y, Canbay E, Liu Y, Ishibashi H, Mizumoto A, Hirano M, Imazato Y, Takao N, Ichinose M, Noguchi K, Li Y, Wakama S, Yamada K, Hatano K, Shintani H, Yoshitake H, Ogura SI. Photodynamic detection of peritoneal metastases using 5-Aminolevulinic Acid (ALA). Cancers (Basel). 2017; 9(3). pii: E23. DOI: 10.3390/cancers9030023. (IF = 5.326) (cited by 1)

[18] Chen JM, Xu J, Gong L, Wang LW, Liu WL, Liu J, Li Y*(corresponding author). Computer-aided prognosis on breast cancer with hematoxylin and eosin histopathology images: a review. Tumor Biol. 2017; 39(3) 1-12. DOI: 10.1177/1010428317694550. (IF = 3.650) (cited by 0)

[19] Wu H, Liu S, Gong J, Liu J, Zhang Q, Leng X, Zhang N, Li Y*(corresponding author). VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction. Cancer Lett. 2017; 393:22-32. DOI: 10.1016/j.canlet.2017.02.007. (IF = 6.375) (cited by 0)

[20] Ji ZH, Peng KW, Yu Y, Li XB, Yonemura Y, Liu Y, Sugarbaker PH, Li Y*(corresponding author). Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases. Int J Hyperthermia. 2017; 33(5):562-570. DOI: 10.1080/02656736.2017.1283065. (IF = 3.262) (cited by 0)

[21] Yonemura Y, Ishibashi H, Hirano M, Mizumoto A, Takeshita K, Noguchi K, Takao N, Ichinose M, Liu Y, Li Y. Effects of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy and neoadjuvant intraperitoneal/systemic chemotherapy on peritoneal metastases from gastric cancer. Ann Surg Oncol. 2017; 24(2):478-485. DOI: 10.1245/s10434-016-5487-6. (IF = 4.041) (cited by 1)

[22] Liu WL, Wang LW, Liu JY, Yuan JP, Chen JM, Wu H, Xiang QM, Yang GF, Li Y*(corresponding author). A comparative performance analysis of multispectral and RGB imaging on HER2 status evaluation for the prediction of breast cancer prognosis. Transl Oncol. 2016; 9(6):521-530. DOI: 10.1016/j.tranon.2016.09.007. (IF = 3.025) (cited by 0)

[23] Wang Y, Wang J, Hao H, Cai M, Wang S, Ma J, Li Y, Mao C, Zhang S. In vitro and in vivo mechanism of bone tumor inhibition by selenium-doped bone mineral nanoparticles. ACS Nano. 2016; 10(11):9927-9937. DOI: 10.1021/acsnano.6b03835. (IF = 13.942) (cited by 5)

[24] Geng XF, Fang M, Liu SP, Li Y*(corresponding author). Quantum dot-based molecular imaging of cancer cell growth using a clone formation assay. Mol Med Rep. 2016; 14(4):3007-12. DOI: 10.3892/mmr.2016.5632. (IF =1.692) (cited by 1)

[25] Liu JY, Yang XJ, Geng XF, Huang CQ, Yu Y, Li Y*(corresponding author). Prognostic significance of tumor-associated macrophages density in gastric cancer: a systemic review and meta-analysis. Minerva Med. 2016; 107(5):314-21. (IF = 1.878) (cited by 3)

[26] Hu M, Li K, Maskey N, Xu Z, Yu F, Peng C, Li Y, Yang G. Corrigendum to "Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer" (Hum Pathol 2015; 46:1872-1880). Hum Pathol. 2016; 54:203-204. DOI: 10.1016/j.humpath.2016.05.001. (IF = 3.014) (cited by 0)

[27] Ji ZH, Peng KW, Li Y*(corresponding author). Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer. Transl Gastroenterol Hepatol. 2016; 1: 69. DOI:10.21037/tgh.2016.08.03. (cited by 0)

[28] Wu HT, Yang XJ, Huang CQ, Sun JH, Ji ZH, Peng KW, Zhang Q, Li Y*(corresponding author). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and decetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies. World J Surg Oncol. 2016; 14:246. DOI 10.1186/s12957-016-1004-4. (IF = 1.600) (cited by 1)

[29] Li Y*(corresponding author), Zhou YF, Liang H, Wang HQ, Hao JH, Zhu ZG, Wan DS, Qin LX, Cui SZ, Ji JF, Xu HM, Wei SZ, Xu HB, Suo T, Yang SJ, Xie CH, Yang XJ, Yang GL. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. World J Gastroenterol. 2016; 22(30): 6906-6916. DOI: 10.3748/wjg.v22.i30.6906. (IF = 3.365) (cited by 4)

[30] Wu HT, Peng KW, Ji ZH, Sun JH, Zhang Q, Yang XJ, Huang CQ, Li Y*(corresponding author). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: results from a Chinese center. Eur J Surg Oncol. 2016; 42(7):1024-34. DOI: 10.1016/j.ejso.2016.04.053. (IF = 3.522) (cited by 4)

[31] Wu HT, Li Y*(corresponding author). Reply to: Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016). Eur J Surg Oncol. 2016; 42(11):1762-1766. DOI: 10.1016/j.ejso.2016.06.405. (IF = 3.522) (cited by 0)

[32] Yonemura Y, Canbay E, Li Y, Coccolini F, Glehen O, Sugarbaker PH, Morris D, Moran B, Gonzaletz-Moreno S, Deraco M, Piso P, Elias D, Batlett D, Ishibashi H, Mizumoto A, Verwaal V, Mahtem H. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. Eur J Surg Oncol. 2016; 42(8):1123-31. DOI: 10.1016/j.ejso.2016.03.016. (IF = 3.522) (cited by 7)

[33] Wang LW, Qu AP, Liu WL, Chen JM, Yuan JP, Wu H, Li Y*(corresponding author), Liu J. Quantum dots-based double imaging combined with organic dye imaging to establish an automatic computerized method for cancer Ki67 measurement. Sci Rep. 2016; 6:20564. DOI: 10.1038/srep20564. (IF = 4.259) (cited by 2)

[34] Sun JH, Ji ZH, Peng KW, Wu HT, Zhang Q, Yonemura Y, Li Y*(corresponding author). Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study. Int J Hyperthermia. 2016; 32(3):289-97. DOI: 10.3109/02656736.2016.1146802. (IF = 2.645) (cited by 0)

[35] Sun JH, Ji ZH, Yu Y, Wu HT, Huang CQ, Zhang Q, Yang XJ, Yonemura Y, Li Y*(corresponding author). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat advanced/recurrent epithelial ovarian cancer: results from a retrospective study on prospectively established database. Transl Oncol. 2016; 9(2):130-8. DOI: 10.1016/j.tranon.2016.02.002. (IF = 3.025) (cited by 1)

[36] Ji ZH, Sun JH, Wu HT, Zhang Q, Peng KW, Li Y*(corresponding author). Assessment of hyperthermic intraperitoneal chemotherapy to eradicate intraperitoneal free cancer cells. Transl Oncol. 2016; 9(1): 18-24. DOI: 10.1016/j.tranon.2015.11.015. (IF = 3.025) (cited by 1)

[37] Liu JY, Geng XF, Li Y*(corresponding author). Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis. Tumor Biol. 2016; 37(5):5715-26. DOI: 10.1007/s13277-016-4887-3. (IF = 3.650) (cited by 0)

[38] Wang YH, Hao H, Li Y, Zhang SM. Selenium-substituted hydroxyapatite nanoparticles and their in vivo antitumor effect on hepatocellular carcinoma. Colloids Surf B Biointerfaces. 2016; 140:297-306. DOI: 10.1016/j.colsurfb.2015.12.056. (IF = 3.902) (cited by 5)

[39] Liu WL, Wang LW, Chen JM, Yuan JP, Xiang QM, Yang GF, Qu AP, Liu J, Li Y*(corresponding author). Application of multispectral imaging in quantitative immunohistochemistry study of breast cancer: a comparative study. Tumor Biol. 2016; 37(4):5013-24. DOI: 10.1007/s13277-015-4327-9. (IF = 3.650) (cited by 1)

[40] Liu J, Li Y*(corresponding author). Trichostatin A and Tamoxifen inhibit breast cancer cell growth by miR-204 and ERα reducing AKT/mTOR pathway. Biochem Biophys Res Commun. 2015; 467(2):242-7. DOI: 10.1016/j.bbrc.2015.09.182. (IF = 2.371) (cited by 6)

[41] Xu H, Chen C, He Y, Tang HW, Zhang ZL, Li Y, Pang DW. Analysis of cancer marker in tissues with Hadamard transform fluorescence spectral microscopic imaging. J Fluoresc. 2015; 25(2): 397-402. DOI: 10.1007/s10895-015-1525-1 (IF = 1.927) (cited by 2)

[42] Hu M, Li K, Maskey N, Xu Z, Yu F, Peng C, Li Y*(corresponding author), Yang G. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer. Hum Pathol. 2015; 46(12): 1872-80. DOI: 10.1016/j.humpath.2015.08.004. (IF = 2.791) (cited by 7)

[43] Hu M, Li K, Maskey N, Xu Z, Peng C, Tian S, Li Y*(corresponding author), Yang G. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer. Int J Clin Exp Pathol. 2015; 8(6): 6910-6918. (IF = 1.581) (cited by 1)

[44] Zeng WJ, Peng CW, Yuan JP, Cui R, Li Y*(corresponding author). Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification. Int J Nanomedicine. 2015; 10: 1759-1768. DOI: 10.2147/IJN.S70228. (IF = 4.320) (cited by 8)

[45] Wang Y, Hao H, Liu H, Wang Y, Li Y, Yang G, Ma J, Mao C, Zhang S. Selenite-Releasing Bone Mineral Nanoparticles Retard Bone Tumor Growth and Improve Healthy Tissue Functions In Vivo. Adv Healthc Mater. 2015; 4(12): 1813-1818. DOI: 10.1002/adhm.201500307. (IF = 5.797) (cited by 4)

[46] Liu J, Li Y*(corresponding author). Trichostatin A and Tamoxifen inhibit breast cancer cell growth by miR-204 and ERalpha reducing AKT/mTOR pathway. Biochem Biophys Res Commun. 2015; 467(2): 242-247. DOI: 10.1016/j.bbrc.2015.09.182. (IF = 2.371) (cited by 6)

[47] Tan Y, Li Y*(corresponding author). HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibiting NR4A1. Biochem Biophys Res Commun. 2015; 466(3): 592-598. DOI: 10.1016/j.bbrc.2015.09.091. (IF = 2.371) (cited by 2)

[48] Yonemura Y, Canbay E, Endo Y, Ishibashi H, Mizumoto A, Li Y, Liu Y, Takeshita K, Ichinose M, Takao N, Saitou T, Noguchi K, Hirane M, Glehen O, Brΰcher B, Sugarbaker P. Comprehensive treatment for the peritoneal metastasis from gastric cancer. World J Surg Proced. 2015; 5(2): 187-197. DOI: 10.5412/wjsp.v5.i2.187. (cited by 0)

[49] Xiang QM, Wang LW, Yuan JP, Chen JM, Yang F, Li Y*(corresponding author). Quantum dot-based multispectral fluorescent imaging to quantitatively study co-expressions of Ki67 and HER2 in breast cancer. Exp Mol Pathol. 2015; 99(1): 133-138. DOI: 10.1016/j.yexmp.2015.06.013. (IF=2.638) (cited by 4)

[50] Chen JM, Qu AP, Wang LW, Yuan JP, Yang F, Xiang QM, Maskey N, Yang GF, Liu J, Li Y*(corresponding author). New breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology images. Sci Rep. 2015; 5, 10690. DOI: 10.1038/srep10690. (IF = 5.228) (cited by 8)

[51] Qu AP, Chen JM, Wang LW, Yuan JP, Yang F, Xiang QM, Maskey N, Yang GF, Liu J*, Li Y*(corresponding author). Segmentation of Hematoxylin-Eosin stained breast cancer histopathological images based on pixel-wise SVW classifier. Sci China Inf Sci. 2015; 58(9): 092105:1-092105:13. DOI: 10.1007/s11432-014-5277-3. (IF = 0.885) (cited by 7)

[52] Liu JY, Yuan JP, Geng XF, Qu AP, Li Y*(corresponding author). Morphological study and comprehensive cellular constituents of milky spots in the human omentum. Int J Clin Exp Pathol. 2015; 8(10): 12877-12884. (IF = 1.581) (cited by 2)

[53] Wei YH, Zhou FX, Li Y, Zhou YF, Anish K, Xu LY, Liao MY. Extrapleural locating method in computed tomography-guided needle biopsies of 1,106 lung lesions. Exp Ther Med. 2015; 10(5):1707-1719. DOI: 10.3892/etm.2015.2735. (IF = 1.280) (cited by 0)

[54] Mei LJ, Wang LW, Huang CQ, Yang XJ, Li Y*(corresponding author). Oral gastrografin radiography for the evaluation of the functional impact of peritoneal carcinomatosis: Correlation with clinicopathological findings. Mol Clin Oncol. 2015; 3(5):979-986. (cited by 1)

[55] Sun J, Chen C, Wei W, Zheng H, Yuan J, Tu YI, Yao F, Wang L, Yao X, Li J, Li Y, Sun S. Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based study. Oncol Lett. 2015; 10(3):1741-1748. DOI: 10.3892/ol.2015.3461. (IF = 1.482) (cited by 3)

[56] Wang LW, Peng CW, Chen C, Li Y*(corresponding author). Quantum dots-based tissue and in vivo imaging in breast cancer researches: current status and future perspectives. Breast Cancer Res Treat. 2015; 151(1): 7-17. DOI: 10.1007/s10549-015-3363-x. (IF = 4.085) (cited by 18)

[57] Yuan JP, Wang LW, Qu AP, Chen JM, Xiang QM, Chen C, Sun SR, Pang DW, Liu J, Li Y*(corresponding author). Quantum dots-based quantitative and in situ multiple imaging on Ki67 and cytokeratin to improve Ki67 assessment in breast cancer. PloS One. 2015; 10(4): e0122734. DOI: 10.1371/journal.pone.0122734. (IF = 3.057) (cited by 19)

[58] 林育林, 张珏, 闫风彩, 蒋茜, 马茹, 杨智冉, 李雁*. 腹腔注射5-氟尿嘧啶治疗腹膜假黏液瘤的人源异种移植模型[J]. 中华实验外科杂志. 2019; 36(10): 1798-1801.

[59] 姬忠贺, 李雁*. 胃癌腹膜转移的研究进展[J]. 中华普通外科杂志. 2019; 34(10): 825-827.

[60] 姬忠贺, 于洋, 刘刚, 张彦斌, 李兵, 安松林, 李鑫宝, 李雁*. 肿瘤细胞减灭术加腹腔热灌注化疗治疗胃癌腹膜转移的预后列线图构建与验证[J]. 中华普通外科杂志. 2019; 34(10): 833-836.

[61] 闫风彩, 李鑫宝, 林育林, 余春开, 周全, 李雁*. 卵巢来源腹膜假黏液瘤临床病理分析[J]. 中国肿瘤临床. 2019; 46(17): 887-890.

[62] 杜雪梅, 李鑫宝, 马玲, 高颖, 孙萍萍, 李雁*. 腹膜恶性间皮瘤中肿瘤浸润淋巴细胞和Ki-67 表达与临床病理特征及预后的关系[J]. 临床与实验病理学杂志. 2019; 35(08): 920-923, 928.

[63] 安松林, 闫风彩, 赵爱民*. 恶性孤立性纤维性肿瘤11例临床诊治分析[J]. 中华普通外科杂志. 2019; 34(06): 498-501.

[64] 李鑫宝, 姬忠贺, 张彦斌, 刘刚, 李兵, 安松林, 于洋, 张凯, 林育林, 李雁*. 肿瘤细胞减灭术加腹腔热灌注化疗围手术期静脉血栓栓塞症的危险因素及防治技术[J]. 肿瘤防治研究. 2019; 46(02): 121-126.

[65] 林育林, 张珏, 闫风彩, 蒋茜, 马茹, 杨智冉, 李雁*. 腹腔注射5-氟尿嘧啶治疗腹膜假黏液瘤的人源异种移植研究[J]. 中华实验外科杂志. 2019; 36(10): 1798-1801.

[66] 林育林, 张珏, 杨智冉, 李鑫宝, 姬忠贺, 许洪斌, 闫风彩, 周全, 彭正, 李雁*. 腹膜高级别黏液癌伴印戒细胞裸小鼠模型的建立及生物学功能鉴定[J]. 中华肿瘤杂志. 2019; 41(12): 923-931.

[67] 闫风彩, 林育林, 赵洪禹, 周全, 昌红, 李雁*. 腹膜假黏液瘤155例病理预后因素分析[J]. 中华病理学杂志. 2019; 48(7): 543-549.

[68] 杜雪梅, 李鑫宝, 于洋, 孙萍萍, 高颖, 昌红, 李雁*. 恶性间皮瘤中PD-1和PD-L1的表达及意义[J]. 临床与实验病理学杂志. 2018; 34(12): 1348-1352.

[69] 姬忠贺, 李雁*. 第11届国际腹膜癌大会简况与思考[J]. 中华医学杂志. 2019; 99(2):158-160.

[70] 庄健美, 李鑫宝, 谈春荣, 陈岩, 刘思琪, 张金荣, 刘璇, 李雁*. 445例腹膜肿瘤细胞减灭术加腹腔热灌注化疗围手术期的输血管理[J]. 中国输血杂志. 2018; 31(12): 1368-1372.

[71] 李鑫宝, 姬忠贺, 于洋, 张彦斌, 刘刚, 李兵, 张凯, 李雁*. 肿瘤细胞减灭术加腹腔热灌注化疗治疗阑尾腺癌腹膜癌的临床研究[J]. 实用肿瘤杂志. 2019; 34(1): 66-71.

[72] 李鑫宝, 姬忠贺, 林育林, 李雁*. 细胞减灭术联合腹腔热灌注化疗治疗腹膜假黏液瘤的研究进展[J]. 医学综述. 2019; 25(5): 915-921.

[73] 于军辉, 李鑫宝, 汪栋, 姚宏伟, 金岚, 杨盈赤, 李雁*. 加速康复外科对老年结直肠癌患者的可行性及安全性[J]. 中国医学科学院学报. 2018; 40(6):730-735.

[74] 姬忠贺, 李鑫宝, 刘刚, 于洋, 林育林, 张彦斌, 李雁*. 肿瘤细胞减灭术加腹腔热灌注化疗治疗110例胃癌腹膜癌临床分析[J]. 中华医学杂志. 2018; 98(38):3079-3083.

[75] 李鑫宝,林育林,姬忠贺, 李雁*. 肿瘤细胞减灭术加腹腔热灌注化疗治疗腹膜假黏液瘤182例分析[J]. 中国肿瘤临床. 2018; 45(18): 943-949.

[76] 林育林, 姬忠贺, 李鑫宝, 赵东兵, 李子禹, 李雁*. 临床医师综合考评方法探析[J]. 中华医学教育杂志. 2018; 38(5): 782-786.

[77] 刘刚, 李鑫宝, 姬忠贺, 刘勇, 张敏, 王勇, 李雁*. D-二聚体联合凝血酶时间检查对腹膜癌患者下肢深静脉血栓排除的诊断价值[J]. 中国普通外科杂志. 2018; 27(6):740-746.

[78] 李雁*, 许洪斌, 彭正, 崔书中, 吴畏, 梁寒, 朱正纲, 陆维祺, 李子禹, 徐惠绵, 刘骞, 赵赟博, 梁斌, 丁克峰, 吴玉梅, 张震宇, 杨国梁, 杨肖军, 周全, 卢一艳, 魏少忠. 肿瘤细胞减灭术加腹腔热灌注化疗治疗腹膜假黏液瘤专家共识[J]. 中华医学杂志. 2019; 99(20): 1527-1535.

[79] 周全, 石峰, 赵洪禹, 李雁, 宋清坤. 腹膜黏液性肿瘤的临床病理分析[J]. 中华病理学杂志. 2018; 47(3): 192-195.

[80] 姬忠贺, 刘洋, Yutaka Yonemura, 李雁*. 5-氨基酮戊酸光动力学诊断腹膜转移癌的研究进展[J]. 首都医科大学学报. 2018; 39(3):469-475.

[81] 孙建华, 姬忠贺, 李雁*. 细胞减灭术加腹腔热灌注化疗治疗复发性卵巢癌[J]. 肿瘤学杂志. 2018; 24(3): 240-246.

[82] 姬忠贺, 梁寒, 季加孚, 于洋, 李鑫宝, 李雁*. 细胞减灭术加腹腔热灌注化疗治疗胃癌腹膜癌的系统分析[J]. 肿瘤防治研究. 2017; 44(12): 796-803.

[83] 于军辉, 刘亚男, 李雁*. 住院医师规范化培训改革后肿瘤外科带教体会[J]. 癌症进展. 2017(11): 1361-1362.

[84] 姬忠贺, 张彦斌, 安松林, 刘刚, 李兵, 于洋, 李鑫宝, 林育林, 李雁*. 细胞减灭术加腹腔热灌注化疗治疗同时性肝细胞癌腹膜转移1例[J]. 肝癌电子杂志. 2017(3).

[85] 刘刚, 姬忠贺, 于洋, 李鑫宝, 张彦斌, 彭开文, 李雁*. 腹膜癌行肿瘤细胞减灭加腹腔热灌注化疗术后高肌红蛋白血症的治疗[J]. 中国肿瘤临床. 2017; 44(17): 867-872.

[86] 张彦斌, 姬忠贺, 刘刚, 于洋, 李兵, 李鑫宝, 王岩, 张展志, 李雁*. 双套管持续冲洗负压引流治疗腹膜癌术后胃肠瘘[J]. 中华普通外科杂志. 2017; 32(6): 505-507.

[87] 彭开文, 张倩, 刘九洋, 李雁*(通讯作者). 肿瘤细胞减灭加腹腔热灌注化疗术后静脉血栓栓塞症的预防[J]. 中国肿瘤临床. 2017; 44(8): 20-25. (cited by 0)

[88] 张倩, 彭开文, 吴晗, 龚俊, 姬忠贺, 李雁*(通讯作者). 胃癌细胞促进网膜脂肪干细胞分化的机制研究[J]. 中国肿瘤临床. 2017; (13):651-655. (cited by 0)

[89] 阎红琳, 袁修学, 陈创, 李雁*(通讯作者), 袁静萍. 基于量子点的多分子成像技术在肿瘤微环境研究中的应用[J]. 中国组织化学与细胞化学杂志. 2017; 26(1):83-89. (cited by 0)

[90] 张倩, 吴晗, 龚俊, 彭开文, 姬忠贺, 李雁*. TGFβ1-Smad3信号通路参与胃癌条件培养基诱导的网膜脂肪干细胞向癌相关成纤维细胞分化[J]. 医学新知杂志. 2017; 27(3): 217-220.

[91] 杨肖军, 刘九洋, 黄超群, 彭春伟, 陈家宽, 李雁*(通讯作者). 肿瘤相关巨噬细胞与胃癌预后关联的Meta分析[J]. 武汉大学学报(医学版). 2017; 38(1):40-43. (cited by 0)

[92] 杨肖军, 黄超群, 彭春伟, 程伏林, 熊斌, 李雁*(通讯作者). 成纤维细胞激活蛋白在胃癌中的表达及临床意义[J]. 武汉大学学报(医学版). 2016; 37(5):757-760. (cited by 0)

[93] 刘九洋, 袁静萍, 李雁*(通讯作者). 腹膜癌网膜标本中乳斑的形态学研究[J]. 肿瘤防治研究. 2016; 43(01): 15-19. (cited by 1)

[94] 杨肖军, 彭春伟, 黄超群, 程伏林, 熊斌, 李雁*(通讯作者). 成纤维细胞激活蛋白对胃癌细胞增殖、迁移、侵袭的影响及机制研究[J]. 武汉大学学报(医学版). 2016; 37(6):900-904. (cited by 0)

[95] 陈佳梅, 屈爱平, 刘文楼, 王林伟, 袁静萍, 刘娟, 李雁*(通讯作者). 基于苏木素-伊红组织病理图像的计算机辅助的乳腺癌预后[J]. 生物医学工程学杂志. 2016; (3):598-603. (cited by 0)

[96] 张展志, 肖萌萌, 李雁, 张能维. 腹腔镜直肠癌保肛手术后吻合口瘘的危险因素与对策[J]. 中华肿瘤防治杂志. 2016; 23(1):40-44. (cited by 4)

[97] 武海涛, 姬忠贺, 张倩, 彭开文, 李雁*(通讯作者). 洛铂联合多西他赛行肿瘤细胞减灭术加腹腔热灌注化疗治疗同时性胃癌腹膜癌[J]. 中国肿瘤临床. 2016; 43(4):146-151. (cited by 2)

[98] 刘鹏飞, 赵斌江, 李天佐, 李雁. 目标导向液体治疗对腹腔热灌注化疗患者机体氧供需平衡及组织灌注的影响[J]. 临床麻醉学杂志. 2016; 32(6):576-580. (cited by 1)

[99] 孙建华, 李雁*(通讯作者).  Fas/FasL系统在肿瘤细胞凋亡中的研究进展[J]. 医学综述. 2015; (20):3694-3696. (cited by 6)

[100] 王群, 邵丽华, 钟燕军, 李雁, 曾庆岭. 阿霉素前体药物PADM靶向治疗高转移性人肝癌裸鼠原位移植模型的动物实验研究[J]. 武汉大学学报(医学版). 2015; 36(6):900-905. (cited by 1)

[101] 孙震, 李雁*(通讯作者). 新辅助化疗治疗进展期胃癌疗效的Meta分析[J]. 武汉大学学报(医学版). 2015; 36(3): 393-398. (cited by 1)

[102] 卢玉兰, 李蓁, 李雁, 蔡红兵. 细胞减灭术中腹腔热灌注化疗治疗卵巢癌Ⅲc期的疗效观察[J]. 武汉大学学报(医学版). 2015; 36(4): 562-567. (cited by 2)

[103] 姬忠贺, 孙建华, 武海涛, 张倩, 彭开文, 李雁*(通讯作者). 腹腔热灌注化疗对腹腔游离癌细胞杀灭效果的评价[J]. 中国肿瘤临床. 2015; 42(19): 963-968. (cited by 6)

[104] 李雁*(通讯作者), 周云峰, 梁寒, 王华庆, 郝继辉, 朱正纲, 万德森, 钦伦秀, 崔书中, 季加孚, 徐惠绵, 魏少忠, 许洪斌, 锁涛, 杨树军, 谢丛华, 杨肖军, 杨国樑. 细胞减灭术加腹腔热灌注化疗治疗腹膜表面肿瘤的专家共识[J]. 中国肿瘤临床. 2015; 42(4): 198-206. (cited by 25)

[105] 杨芳, 王林伟, 袁静萍, 李雁*(通讯作者). 乳腺癌综合治疗的发展和现状[J]. 医学新知. 2015; (2):111-114. (cited by 3)

[106] 于洋, 李雁*(通讯作者). 胃癌腹膜转移癌治疗研究进展及我国治疗现状[J]. 肿瘤防治研究. 2015; (08): 829-834. (cited by 1)

[107] 杨芳, 李雁*(通讯作者). 乳腺浸润性微乳头状癌临床病理分析[J]. 现代肿瘤医学. 2015; (12): 1670-1673. (cited by 2)

[108] 郑建伟, 张晓梅, 李雁, 易继林, 秦仁义, 吴在德, 薛新波, 申铭. 黑色素瘤分化相关基因-7逆转上皮-间充质转化抑制肝癌细胞的侵袭转移机制[J]. 中华实验外科杂志. 2015; 32(10):2342-2346. (cited by 0)

[109] 刘九洋, 李雁*(通讯作者). 乳斑与腹膜转移癌的相关性研究进展[J]. 肿瘤防治研究. 2015; (06): 618-621. (cited by 0)

[110] 耿霞飞, 刘少平, 方敏, 李雁*(通讯作者). 量子点分子探针双标记技术研究癌细胞克隆生长行为[J]. 肿瘤防治研究. 2015; (02): 103-107. (cited by 0)